Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clinics (Sao Paulo). 2010 Feb;65(2):221-31. doi: 10.1590/S1807-59322010000200015.

Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.

Author information

  • 1Department of Gastroenterology, Fatih University Medical School - Ankara, Turkey.

Abstract

The inflammatory bowel diseases, consisting of Crohn's disease, ulcerative colitis and indeterminate colitis, are distinguished by idiopathic and chronic inflammation of the digestive tract. The distinction between inflammatory bowel diseases and functional bowel disorders, such as irritable bowel syndrome, can be complex because they often present with similar symptoms. Rapid and inexpensive noninvasive tests that are sensitive, specific and simple are needed to prevent patient discomfort, delay in diagnosis, and unnecessary costs. None of the current commercially available serological biomarker tests can be used as a stand-alone diagnostic in clinics. Instead, these are used as an adjunct to endoscopy in diagnosis and prognosis of the disease. Along these lines,, fecal lactoferrin and calprotectin tests seem to be one step further from other tests with larger number of studies, higher sensitivity and specificity and wider availability.

KEYWORDS:

Diagnosis; Fecal markers; Inflammatory bowel disease; Serology

PMID:
20186307
[PubMed - indexed for MEDLINE]
PMCID:
PMC2827710
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Scientific Electronic Library Online Icon for PubMed Central
    Loading ...
    Write to the Help Desk